The FY2025 (Dec) proxy of Edgewise Therapeutics names 20 peer companies for pay. Pay versus performance data of Edgewise Therapeutics for that year is not on file, so it has no rank.
Pay peer group, FY2025 (Dec) proxy
| Scholar Rock Holding | ||
| Cogent Biosciences | ||
| Protagonist Therapeutics | ||
| Enliven Therapeutics | ||
| IDEAYA Biosciences | ||
| Kymera Therapeutics | ||
| Beam Therapeutics | ||
| Denali Therapeutics | ||
| 89bio | Not disclosed | Not disclosed |
| Aerovate Therapeutics | Not disclosed | Not disclosed |
| Akero Biosciences | Not disclosed | Not disclosed |
| Arcus Biosciences | Not disclosed | Not disclosed |
| Avidity Biosciences | Not disclosed | Not disclosed |
| Dyne Therapeutics | Not disclosed | Not disclosed |
| Janux Therapeutics | Not disclosed | Not disclosed |
| Keros Therapeutics | Not disclosed | Not disclosed |
| Morphic | Not disclosed | Not disclosed |
| Pliant Therapeutics | Not disclosed | Not disclosed |
| Rocket Pharmaceuticals | Not disclosed | Not disclosed |
| Zentalis Pharmaceuticals | Not disclosed | Not disclosed |
20 companies
Changes by year
No proxy on file names a change to the peer group.
The comes from the company's proxy. CEO pay and of each company come from its own Pay versus Performance table for the same fiscal year. Each company counts TSR from its own start year, so two values compare only when the start years match.